Schwazze Q1 FY23 Revenue Grows 26% YoY, What About Profit?

Medicine Man Technologies Inc. operating as Schwazze, SHWZ SHWZ released financial results for the first quarter 2023, revealing revenue of $40 million, an increase of 26% compared to $31.8 million in Q1 2022.

Q1 2023 Financial Highlights

Gross profit of $23.0 million, an increase of 111% compared to $10.9 million in Q1 2022
Gross profit margin of 58% compared to 34% in Q1 2022
Adjusted EBITDA of $14.5 million was 36.3% of revenue, compared to $7.9 million and 24.7% of revenue for Q1 2022
Net income of $1.7 million, an increase of $28.5 million compared to net loss of $26.8 million in Q1 2022
Cash and cash equivalents at the end of the period were $35.2 million.

"To date, we have opened, acquired, or announced pending acquisitions of 60 dispensaries with six operating cultivations and three manufacturing facilities across Colorado and New Mexico," stated Justin Dye, CEO of Schwazze. "We believe our growing variety of retail brands resonate strongly with our cannabis customers, and the team is well-positioned to play offense as we continue to strengthen our position for shareholders."

Photo: Benzinga edit with photo by Kindel Media on Pexels

Schwazze To Acquire One Medical Cannabis Dispensary In Denver, Colorado

Schwazze Launches Every Day Weed, A Half Ounce Pre-Ground Flower Product

Market News and Data brought to you by Benzinga APIs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Cannabis rescheduling seems to be right around the corner